StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a note issued to investors on Friday. The brokerage set a “hold” rating on the software maker’s stock.
Veradigm Stock Performance
Shares of NASDAQ MDRX opened at $9.45 on Friday. Veradigm has a one year low of $5.01 and a one year high of $11.80. The business has a 50-day moving average price of $10.01 and a two-hundred day moving average price of $9.73.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC purchased a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- Best Stocks Under $10.00
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- How to Invest in Small Cap Stocks
- Top 3 ETFs to Hedge Against Inflation in 2025
- How to Calculate Inflation Rate
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
